Korean J Hepatol.
2006 Dec;12(4):530-538.
Clinical Usefulness of delta MELD to Predict the Survival of Patients with Liver Cirrhosis
- Affiliations
-
- 1Institute for Digestive Research, Department of Internal Medicine, Soon Chun Hyang University, College of Medicine, Seoul, Korea.
- 2Department of Gastroenterology and Hepatology, Gil Medical Center, Gachon University, Incheon, Korea. kimys@gilhospital.com
Abstract
- <0.001) compared with 0.575 for MELD score and 0.636 for CP score at 6 month-mortality; the area was 0.727, 0.594 and 0.657 at 12 month-mortality; 0.693, 0.587 and 0.639 at 24 month-mortality, respectively. The patients with delta MELD/month more than 1.0 had resulted in the higher mortality at 6, 12 and 24 months. The delta MELD/month was associated with mortality and was an independent prognostic predictor with a risk ratio of 1.679 (95% CI: 1.381-2.042, P<0.001). CONCLUSIONS: Determination of delta MELD could be better prognostic predictor for patients with liver cirrhosis than initial MELD and CP score.
Keyword
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- Usefulness of delta MELD/month for Prediction of the Mortality in the First Episode of Variceal Bleeding Patients with Liver Cirrhosis: Comparison with CTP, MELD score and delta CTP/month
- Changes of MELD: Can Exceed Child-Pugh's Authority?
- Important predictor of mortality in patients with end-stage liver disease
- The Effect of Model for End-Stage Liver Disease 3.0 on Disparities between Patients with and without Hepatocellular Carcinoma in Korea
- Prognostic indicators and risk factors for the in-hospital mortality rate of patients with cirrhosis
